Veterinary Medicines

Clavoral 500/125 mg tablet for dogs (strength 500 mg amoxicillin + 125 mg

Authorised
  • Amoxicillin trihydrate
  • Clavulanic acid
Download as PDF

Product identification

Medicine name:
Clavoral 500/125 mg tablet for dogs (strength 500 mg amoxicillin + 125 mg
CLAVUBACTIN 500/125 MG COMPRIMES POUR CHIENS
Active substance:
  • Amoxicillin trihydrate
  • Clavulanic acid
Target species:
  • Dog
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Amoxicillin trihydrate
    500.00
    milligram(s)
    /
    1.00
    Tablet
  • Clavulanic acid
    125.00
    milligram(s)
    /
    1.00
    Tablet
Pharmaceutical form:
  • Tablet
Withdrawal period by route of administration:
  • Oral use
    • Dog
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ01CR02
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • France
Package description:
  • Carton containing 5 aluminium/aluminium blister strips each strip with 4 tablets corresponding to 20 tablets per carton.
  • Carton containing 5 aluminium/aluminium blister strips each strip with 2 tablets corresponding to 10 tablets per carton.
  • Carton containing 25 aluminium/aluminium blister strips each strip with 4 tablets corresponding to 100 tablets per carton.
  • Carton containing 25 aluminium/aluminium blister strips each strip with 10 tablets corresponding to 250 tablets per carton.
  • Carton containing 10 aluminium/aluminium blister strips each strip with 10 tablets corresponding to 100 tablets per carton.
  • Carton containing 1 aluminium/aluminium blister strip with 10 tablets corresponding to 10 tablets per carton.

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Hybrid application (Article 13(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Le Vet. B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Lelypharma B.V.
Responsible authority:
  • French Agency For Food, Environmental And Occupational Health & Safety
Authorisation number:
  • FR/V/7762548 5/2010
Date of authorisation status change:
Reference member state:
  • Netherlands
Procedure number:
  • NL/V/0149/003
Concerned member states:
  • Czechia
  • France
  • Hungary
  • Iceland
  • Ireland
  • Italy
  • Poland
  • Slovakia
  • Spain
  • United Kingdom (Northern Ireland)

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
French (PDF)
Published on: 7/04/2022
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."